HT
ABEO icon

Headlands Technologies’s Abeona Therapeutics ABEO Stock Holding History

Headlands Technologies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$773K Buy
125,090
+61,745
+97% +$339K 0.08% 301
2026
Q1 		$284K Buy
+63,345
New +$317K 0.03% 512

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Headlands Technologies's ABEO Position: Q2 2026 in Review

Headlands Technologies increased its Abeona Therapeutics (ABEO) stake by 97% in Q2 2026, buying an estimated $339K and bringing the position to 125,090 shares worth $773K. The position accounts for 0.08% of the portfolio, ranked #301.

Headlands Technologies first reported a position in ABEO in Q1 2026 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Headlands Technologies held 125,090 shares of Abeona Therapeutics worth $773K as of Q2 2026.
  • Headlands Technologies bought 61,745 Abeona Therapeutics shares in Q2 2026, an estimated $339K.
  • Abeona Therapeutics made up 0.08% of Headlands Technologies's portfolio in Q2 2026, its #301 holding.
  • Headlands Technologies first reported a position in Abeona Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.